Check out this month's newsletter!
关于我们
Contagion? is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly digital journal, email newsletters, and social media outlets we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the health care community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
- 网站
-
https://www.contagionlive.com
Contagion_Live的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 201-500 人
- 总部
- Cranbury，NJ
- 类型
- 私人持股
- 领域
- Infectious Diseases、Publishing、Healthcare和Communications
地点
-
主要
获取路线
2 Clarke Drive
Suite 100
US，NJ，Cranbury，08512
Contagion_Live员工
动态
-
Had a wonderful time meeting and interviewing Dr. Nilu Goonetilleke, Associate Professor of Medicine at UNC School of Medicine, discussing The M&M Study and The CM Study at CROI 2025. Stay tuned for the published interviews! You can find our #CROI2025 conference coverage here: https://lnkd.in/gMcApiUZ
-
-
A great start to CROI 2025 this Sunday in sunny San Francisco! We’re kicking off our interviews this afternoon with researchers discussing their posters and presentations—stay tuned for updates. Which presentations or workshops from today have you found particularly insightful so far? Let’s engage in conversation and collaboration in the comments! #CROI2025
-
-
We've arrived in San Francisco for CROI 2025! Excited to connect with clinicians and discuss inspiring research. ?? #CROI2025
-
-
We are proud to work alongside Jacinda C. Abdul-Mutakabbir, PharmD, MPH, whose expertise in antimicrobial resistance has made a lasting impact. This International Women’s Day, we celebrate her dedication, leadership, and contributions to Contagion. Check out her latest work here: https://bit.ly/4hhhO4a
-
-
#ICYMI In the latest Society of Infectious Diseases Pharmacists (SIDP) Bench to Bedside column, Dr. Lindsey M. Childs-Kean and Dr. Megan Klatt review new guidance on the treatment of drug-susceptible and drug-resistance Mycobacterium tuberculosis infections.
-
This week, read and listen to our coverage of advancing RNA therapies and new vaccine options, Vaxart's oral norovirus vaccine and Recce Pharmaceuticals' synthetic gel for ABSSSI, and more.?? https://lnkd.in/eKUiFgxr
-
Dr. Stacy Lindborg, CEO of IMUNON, discusses the promising results of the IMNN-101 vaccine in its Phase 1 trial, showing a 2- to 4-fold increase in neutralizing antibodies and cross-reactivity against multiple COVID variants. The vaccine demonstrated a strong immune response and no serious adverse events, with potential for global distribution due to its stability at various temperatures. Listen to our interview here: https://lnkd.in/e3T5xUUS
-
#Breaking Texas reports 39 more #measles cases since Tuesday, and the CDC says there are 222 cases in the US. #measlesoutbreak